Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company
08 mars 2017 07h00 HE
|
Capnia, Inc.
Lead Clinical Asset Entering Phase II/III Development in 2017 for the Treatment of Prader-Willi Syndrome Raises $10 Million in Concurrent Financing; Cash Runway Through Key Milestones REDWOOD...
Capnia to Present at the 19th Annual BIO CEO & Investor Conference
07 févr. 2017 07h00 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics...
Capnia and Essentialis Announce Merger to Create Rare Disease Therapeutics Company
27 déc. 2016 08h45 HE
|
Capnia, Inc.
Combined Company to Focus on Advancing Novel, Late-Stage Asset for the Treatment of Prader-Willi Syndrome, a Devastating, Orphan Disease Enrollment in a Phase II/III Clinical Trial Expected to...
Capnia Reports Third Quarter 2016 Financial Results
14 nov. 2016 16h05 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics...
Capnia to Present at Upcoming Investor Conferences
06 sept. 2016 07h00 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Reports Second Quarter 2016 Financial Results
12 août 2016 16h05 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Announces Private Placement of Up to $13.8 Million of Convertible Preferred Stock
29 juin 2016 19h00 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., June 29, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Expands Commercial Launch of Serenz® Allergy Relief to Ireland
15 juin 2016 07h00 HE
|
Capnia, Inc.
REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Announces Exclusive Distribution Agreement for CoSense® End-Tidal Carbon Monoxide Monitor in India
07 juin 2016 16h05 HE
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., June 07, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia to Present at 2016 Marcum MicroCap Conference
25 mai 2016 16h05 HE
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...